Introduction
After removing plasma from the unit of donated blood, RBCs intended for transfusion are kept in PCV bags, at 4-6 o C as so-called erythrocyte concentrates (ECs). Application of suitable preservation solutions, for example CPD (citrate-phosphate-dextrose-adenine) + SAGM (saline-adenine-glucose-mannitol) allows RBCs to be stored up to 42 days [1, 2] . EC can be stored together with leucocytes or can also be deprived of those cells by filtration. Retrospective clinical studies point out the adverse transfusion effects of long stored non-or leucoreduced RBCs on the recipient's recovery [3] [4] [5] [6] [7] [8] [9] . These concerns mostly patients of the cardiology departments, with acute coronary syndrome, ischemic heart disease or after coronary interventions, who are particularly susceptible for effects of hypoxia, electrolyte imbalance, activation of thrombosis, presence of proinflammatory factors and haemolysis. The correlation was observed between long stored non-leucoreduced RBCs transfusions and an increased intensive care unit length of stay, sepsis, acute renal dysfunction, transfusionrelated acute lung injury, multiorgan failure and also increased in-hospital and out-of-hospital mortality. In recent years there has been increasing interest in the idea that allogeneic blood transfusions may be associated with so-called transfusion-related immunomodulation (TRIM) that refers to increase in the risk of infections, cancer recurrence and autoimmunisation.
It is well known that during the storage under blood bank conditions, RBCs undergo a number of biochemical, morphological and metabolic changes known as "storage lesions" [10] [11] [12] [13] [14] [15] . For example, it is well described, that due to accumulation of lactic acid in the blood bag, the pH decreases, and this increases phosphatase enzyme activity, which results in 2,3-diphosphoglycerol (2,3-DPG) degradation. Low level of 2,3-DPG results in increased haemoglobin affinity for oxygen and thereby causes diminished delivery of oxygen to tissues. During RBCs storage period there are also changes in ATP level what reflects on reology of erythrocyte, loss of S-nitrosothiol-haemoglobin (SNO-Hb) and thereby decreased NO production and further vasodilatation, as well as membranous band 3 protein and some other proteins rearrangements, that may lead to erythrocyte disintegration and haemolysis.
According to some scientists, in vivo RBC lifespan is regulated by autoimmunological process [16] [17] [18] [19] [20] . Under the erythrocyte aging, the amount of some surface molecules e.g. sialic acid is reduced, while other RBC membrane structures like band 3 and Rh proteins emerge. Therefore, it is postulated that erythrocytes obtain new antigenic properties and in reaction with natural autoantibodies are removed from bloodstream by spleen macrophages after around 120 days.
Similarly act warm IgG autoantibodies in AIHA, however the RBC lifespan is significantly shortened and sometimes warm IgG autoantibodies preferably interact with the old rather than young patient's RBCs.
In this study we aimed to evaluate changes of interaction of fresh vs. stored donor RBCs with autoantibodies of AIHA suffering patients.
Material and methods

Red blood cells sampling
RBC samples were obtained from the drains of the EC bags containing CPD + SAGM. For the reaction with autoantibodies analysis, RBC samples obtained from 108 ECs were used: 3 groups of 24 samples of fresh (3 to 5 days after donation) leucoreduced ECs and non-and leucoreduced 6 weeks stored ECs, then 3 groups of 12 samples of fresh leukoreduced ECs and non-and leukoreduced 3 weeks stored ECs.
In order to perform the morphological analysis, 60 leucoreduced RBC samples were taken at the beginning and at the end of their storage and measurement was carried out using the haematological analyzer (Beckman Coulter, USA).
Autoantibodies
The serological diagnosis of warm-type AIHA in 10 patients was based on a positive gel direct antiglobulin test with monospecific anti-human globulin serum anti-IgG (DiaMed-ID, Switzerland). The RBC eluates were prepared by the acid elution procedure. One volume of washed packed RBCs was mixed with two volumes of an acid/EDTA buffer (pH 1.5), incubated for 2 minutes, then centrifuged and the supernatant (eluate) neutralized with the TRIS buffer. Studied RBC autoantibodies were typical, non-specific, what means that they were panreactive and gave the same reactions with all panel RBCs routinely used in serological laboratories, regardless of donors' phenotypes. The eluates from each sample were combined and used for titration study.
Autoantibody reactivity
Two milliliters of mixture of eluates were prepared in serial dilutions from 1/2 to 1/256 with PBS and studied by the microcolumn gel-indirect antiglobulin test with all 108 samples of RBCs according to the manufacturer's instruction (IAT; LISSCoombs, DiaMed-ID, Switzerland). Obtained results were presented as the score values for the last 3 dilutions, where the reactions were observed. IAT results are semiquantitative and strength of reactions usually are noted as 4+, 3+, 2+, 1+, 1+ weak , negative or as respective numbers 12, 10, 8, 5, 3, 0. The way of examination can be modified. We introduced additional grades 2.5+, 1.5+, +/-and appropriate numbers (9, 7, 2). In our titration study made parallel with RBCs from three EC populations, first dilutions of autoantibodies ex. 1/2, 1/4, 1/8 gave equal results 4+, then differentiated in three next dilutions ex. 1/16, 1/32, 1/64 and these were counted as score. Reactions of agglutination were fixed and easy to read because we used microcolumn gel IAT.
Statistics
For statistical analysis, the t-student test was applied for groups of related (morphology) as well as for groups of unrelated (autoantibody reactivity with RBCs).
Results
The determined autoantibody titer for fresh RBCs was 32 or 64, and in case of 6 weeks stored RBCs was higher and was 64 or 128. The score values were: 10.25 ±3.45 for
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fresh RBCs, 15.41 ±2.08 for stored non-leucoreduced and 16.25 ±3.01 for stored leucoreduced RBCs. This observed difference in RBC-autoantibody reactivity of fresh vs. stored RBCs was statistically significant, with p < 0.001. There was a slight increase in autoantibody titer and mean score value of stored, non-leucoreduced RBCs in comparison with stored leucoreduced RBCs, however, this difference was statistically not significant (Fig. 1) . Comparing autoantibody reactivity of fresh vs. 3 weeks stored RBCs we noticed very slight increase against non-leukoreduced RBCs but it was statistically not significant and in these three groups score values were almost equal.
Analysis of morphological parameters revealed statistically significant difference in MCV of short (3-5 days) vs. long (6 weeks) stored RBCs: 91.5 ±4.08 fL vs. 95.4 ±4.06 (p < 0.001) (Fig. 2) .
Discussion
Preparation process and storage of all of the components of whole blood, including RBCs depends on the local legislation and process is strictly controlled. The last verification criterion, according FDA requirements is determining the validity of the storage period basing on method of the survival of labeled stored RBCs in the volunteers bloodstream. At the last day of the EC unit storage, RBCs should be safe and effective like on the day of donation. It is established that lowered 2,3-DPG, ATP and RBC reological properties are recovered within recipient's blood circulation in several hours after transfusion. Results of our study showed that during storage period, reactivity of RBCs with autoantibodies was increased. It could indicate the direct changes in the antigenic structure. However, the alteration of RBCautoantibody reactivity was not visibly dependent on the presence of leucocytes, their products e.g. proteolityc enzymes, that could be responsible for the RBC membrane modification. On the other hand, there was a significant increase in MCV values in 6 th week of RBC storage. Increased MCV of RBCs can cause easier accessibility of the antigen determinants for autoantibodies. Regardless of the reason of observed stored RBC changes, their increased reactivity with pathological or physiological autoantibodies can lead to the intensified removal of transfused erythrocytes from recipients bloodstream and in consequence adverse outcomes of the blood transfusion. 
